These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38553619)

  • 1. Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?
    Porcaro AB; Bianchi A; Panunzio A; Gallina S; Serafin E; Tafuri A; Trabacchin N; Orlando R; Ornaghi PI; Mazzucato G; Vidiri S; D'Aietti D; Montanaro F; Brusa D; Patuzzo GM; Artoni F; Baielli A; Migliorini F; De Marco V; Veccia A; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
    Int Urol Nephrol; 2024 Aug; 56(8):2597-2605. PubMed ID: 38553619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single tertiary referral center.
    Porcaro AB; Bianchi A; Panunzio A; Gallina S; Tafuri A; Serafin E; Orlando R; Mazzucato G; Vidiri S; D'Aietti D; Montanaro F; Marafioti Patuzzo G; Artoni F; Baielli A; Ditonno F; Rizzetto R; Veccia A; Gozzo A; De Marco V; Brunelli M; Cerruto MA; Antonelli A
    Ther Adv Urol; 2024; 16():17562872241229260. PubMed ID: 38348129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b.
    Porcaro AB; Panunzio A; Orlando R; Montanaro F; Baielli A; Artoni F; Gallina S; Bianchi A; Mazzucato G; Serafin E; Patuzzo GM; Veccia A; Rizzetto R; Brunelli M; Migliorini F; Bertolo R; Tafuri A; Cerruto MA; Antonelli A
    Int Braz J Urol; 2024; 50(4):450-458. PubMed ID: 38743063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.
    Takeshima Y; Yamada Y; Teshima T; Fujimura T; Kakutani S; Hakozaki Y; Kimura N; Akiyama Y; Sato Y; Kawai T; Yamada D; Kume H
    BMC Cancer; 2021 May; 21(1):501. PubMed ID: 33947348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact and Clinical Implications of Unfavorable Upgrading in Low-Risk Prostate Cancer after Robot-Assisted Radical Prostatectomy: Results of a Single Tertiary Referral Center.
    Porcaro AB; Panunzio A; Bianchi A; Sebben M; Gallina S; De Michele M; Orlando R; Serafin E; Mazzucato G; Vidiri S; D'Aietti D; Princiotta A; Montanaro F; Marafioti Patuzzo G; De Marco V; Brunelli M; Pagliarulo V; Cerruto MA; Tafuri A; Antonelli A
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center.
    Porcaro AB; Bianchi A; Gallina S; Panunzio A; Tafuri A; Serafin E; Orlando R; Mazzucato G; Ornaghi PI; Cianflone F; Montanaro F; Artoni F; Baielli A; Ditonno F; Migliorini F; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
    Cancers (Basel); 2024 Jun; 16(11):. PubMed ID: 38893256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy.
    Nocera L; Wenzel M; Collà Ruvolo C; Würnschimmel C; Tian Z; Gandaglia G; Fossati N; Chun FKH; Mirone V; Graefen M; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
    World J Urol; 2022 Jan; 40(1):103-110. PubMed ID: 34436637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen levels and proportion of biopsy positive cores are independent predictors of upgrading patterns in low-risk prostate cancer.
    Porcaro AB; Inverardi D; Corsi P; Sebben M; Cacciamani G; Tafuri A; Processali T; Pirozzi M; Mattevi D; De Marchi D; Amigoni N; Rizzetto R; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Minerva Urol Nefrol; 2020 Feb; 72(1):66-71. PubMed ID: 30298710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection.
    Porcaro AB; Panunzio A; Tafuri A; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Gozzo A; Serafin E; Cianflone F; Migliorini F; Vidiri S; Di Filippo G; Novella G; Brunelli M; Shakir A; Pagliarulo V; Cerruto MA; Siracusano S; Antonelli A
    Urol Int; 2022; 106(9):928-939. PubMed ID: 35081537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease.
    Porcaro AB; Panunzio A; Serafin E; Bianchi A; Gallina S; Mazzucato G; Vidiri S; D'Aietti D; Orlando R; Ditonno F; Montanaro F; Marafioti Patuzzo G; Bailelli A; Artoni F; Zecchini Antoniolli S; Rizzetto R; Brunelli M; Siracusano S; Cerruto MA; Tafuri A; Antonelli A
    Int Urol Nephrol; 2023 May; 55(5):1139-1148. PubMed ID: 36943597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis.
    Kesch C; Pantea V; Soeterik T; Marquis A; la Bombarda G; Morlacco A; Barletta F; Radtke JP; Darr C; Preisser F; Zattoni F; Marra G; van den Bergh RCN; Hadaschik B; Gandaglia G;
    World J Urol; 2023 Feb; 41(2):427-434. PubMed ID: 36534151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center.
    Porcaro AB; Bianchi A; Gallina S; Panunzio A; Serafin E; Mazzucato G; Orlando R; Montanaro F; Patuzzo GM; Baielli A; Artoni F; Ditonno F; Vidiri S; D'Aietti D; Migliorini F; Rizzetto R; Veccia A; Gozzo A; Brunelli M; Tafuri A; Cerruto MA; Antonelli A
    Aging Clin Exp Res; 2023 Sep; 35(9):1881-1889. PubMed ID: 37337076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy.
    Porcaro AB; Tafuri A; Panunzio A; Cerrato C; Bianchi A; Gallina S; Vidiri S; D'Aietti D; Serafin E; Mazzucato G; Princiotta A; Brusa D; Brunelli M; Pagliarulo V; Cerruto MA; Antonelli A
    Asian J Androl; 2023 Sep; 25(5):556-563. PubMed ID: 36629157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy.
    Takeuchi N; Sakamoto S; Nishiyama A; Horikoshi T; Yamada Y; Iizuka J; Maimaiti M; Imamura Y; Kawamura K; Imamoto T; Komiya A; Ikehara Y; Akakura K; Ichikawa T
    Clin Genitourin Cancer; 2018 Aug; 16(4):e817-e829. PubMed ID: 29576444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of biopsy and pathologic ISUP grading in salvage radical prostatectomy patients for recurrent prostate cancer.
    Preisser F; Würnschimmel C; Pose RM; Heinze A; Steuber T; Michl U; Salomon G; Mandel P; Graefen M; Tilki D
    Prostate; 2022 Feb; 82(2):254-259. PubMed ID: 34807461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
    Kim H; Jung G; Kim JH; Byun SS; Hong SK
    Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors.
    Porcaro AB; Orlando R; Panunzio A; Tafuri A; Baielli A; Artoni F; Montanaro F; Gallina S; Bianchi A; Mazzucato G; Serafin E; Veccia A; Boldini M; Treccani LP; Rizzetto R; Brunelli M; Migliorini F; Bertolo R; Cerruto MA; Antonelli A
    J Robot Surg; 2024 Mar; 18(1):134. PubMed ID: 38520651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of palpable prostate tumors on disease progression after robot-assisted radical prostatectomy: a single-center experience.
    Porcaro AB; Gallina S; Bianchi A; Tafuri A; Serafin E; Panunzio A; Mazzucato G; Orlando R; Ditonno F; Ornaghi PI; Rizzetto R; Cerrato C; De Marco V; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
    J Robot Surg; 2023 Oct; 17(5):2471-2477. PubMed ID: 37486540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear extent of positive surgical margin impacts biochemical recurrence after robot-assisted radical prostatectomy in a high-volume center.
    Porcaro AB; Tafuri A; Sebben M; Amigoni N; Shakir A; Corsi P; Processali T; Pirozzi M; Rizzetto R; Bernasconi R; Cerrato C; Tiso L; Migliorini F; Novella G; Brunelli M; De Marco V; Siracusano S; Artibani W
    J Robot Surg; 2020 Aug; 14(4):663-675. PubMed ID: 31893344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.